Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Tailored Nanoscale Contrast Agents for Magnetic Resonance Imaging

Published

Author(s)

Alexander J. Barker, Brant Cage, Stephen E. Russek, Ruchira Garg, Robin Shandas, Conrad Stoldt

Abstract

Two potential molecular imaging vectors are investigated for material properties and magnetic resonance imaging (MRI) contrast improvement. Monodisperse magnetite (Fe3O4) nanocrystals ranging in size from 7 to 22 nm are solvothermally synthesized by thermolysis of Fe(III) acetylacetonate (Fe(AcAc)3), both with and without the use of heptanoic acid (HA) as a capping ligand. For the resulting Fe3O4 nanocrystals, X-Ray diffraction (XRD), transmission electron microscopy (TEM), high-resolution TEM (HRTEM), and superconducting quantum interference device magnetometry (SQUID) is used to identify the average particle size, monodispersity, crystal symmetry, and magnetic properties of the ensembles as a function of time. The characterization study indicates that the HA synthesis route at 3 hours produced nanoparticles with the greatest magnetic anisotropy (15.8 x 104 J/m3). The feasibility of Fe8 single molecule magnets (SMMs) as a potential MRI contrast agent is also examined. SQUID magnetization measurements are used to determine anisotropy and saturation of the potential agents. The effectiveness of the Fe3O4 nanocrystals and Fe8 as potential MRI molecular probes is evaluated by MRI contrast improvement using 1.5 mL phantoms dispersed in de-ionized water. Results indicate that the magnetically optimized Fe3O4 nanocrystals and Fe8 SMMs hold promise for use as contrast agents based on the reported MRI images and solution phase T1/T2 shortening.
Proceedings Title
Proceedings of IMECE2005, 2005 ASME International Mechanical Engineering Congress and Exposition
Conference Dates
November 5-11, 2005
Conference Location
Orlando, FL
Conference Title
ASME International Mechanical Engineering Congress and Exposition

Keywords

contrast agent, Fe<sub>3</sub>O<sub>4</sub>, Fe<sub>8</sub>, MRI
Created December 30, 2005, Updated February 19, 2017